BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 1705690)

  • 1. Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.
    Ceci JD; Kovatch RM; Swing DA; Jones JM; Snow CM; Rosenberg MP; Jenkins NA; Copeland NG; Meisler MH
    Oncogene; 1991 Feb; 6(2):323-32. PubMed ID: 1705690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin receptor characterization and cholecystokinin-A receptor messenger RNA expression in transgenic mouse pancreatic carcinomas and dysplastic pancreas.
    Povoski SP; Zhou W; Longnecker DS; Bell RH
    Oncol Res; 1994; 6(9):411-7. PubMed ID: 7703527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
    Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
    Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The uteroglobin promoter targets expression of the SV40 T antigen to a variety of secretory epithelial cells in transgenic mice.
    Sandmöller A; Halter R; Gómez-La-Hoz E; Gröne HJ; Suske G; Paul D; Beato M
    Oncogene; 1994 Oct; 9(10):2805-15. PubMed ID: 8084586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic mice bearing the polyomavirus large T antigen directed by 2.1 kb of the keratin 19 promoter develop bronchiolar papillary tumors with progression to lung adenocarcinomas.
    Lebel M; Webster M; Muller WJ; Royal A; Gauthier J; Mes-Masson AM
    Cell Growth Differ; 1995 Dec; 6(12):1591-600. PubMed ID: 9019164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct hypomyelinated phenotypes in MBP-SV40 large T transgenic mice.
    Jensen NA; Smith GM; Shine HD; Garvey JS; Hood L
    J Neurosci Res; 1993 Feb; 34(3):257-64. PubMed ID: 7681114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperplasia in multiple smooth muscle tissues in transgenic mice expressing a temperature-sensitive SV40 T-antigen under the control of smooth muscle alpha-actin regulatory sequences.
    March KL; Sandusky G; Fan L
    Oncogene; 1999 Jun; 18(25):3773-82. PubMed ID: 10391686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenesis in transgenic mice in which the SV40 T antigen is driven by the brain-specific FGF1 promoter.
    Chiu IM; Touhalisky K; Liu Y; Yates A; Frostholm A
    Oncogene; 2000 Dec; 19(54):6229-39. PubMed ID: 11175337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple neuroendocrine tumours in transgenic mice induced by c-kit-SV40 T antigen fusion genes.
    Bossé P; Bernex F; De Sepulveda P; Salaün P; Panthier JJ
    Oncogene; 1997 Jun; 14(22):2661-70. PubMed ID: 9178764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter.
    Danks RA; Orian JM; Gonzales MF; Tan SS; Alexander B; Mikoshiba K; Kaye AH
    Cancer Res; 1995 Oct; 55(19):4302-10. PubMed ID: 7671240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The c-myc and PyMT oncogenes induce different tumor types in a somatic mouse model for pancreatic cancer.
    Lewis BC; Klimstra DS; Varmus HE
    Genes Dev; 2003 Dec; 17(24):3127-38. PubMed ID: 14681205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperplasia and tumors of the islets of Langerhans in mice bearing an elastase I-SV40 T-antigen fusion gene.
    Bell RH; Memoli VA; Longnecker DS
    Carcinogenesis; 1990 Aug; 11(8):1393-8. PubMed ID: 2167183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice.
    Perraud F; Yoshimura K; Louis B; Dalemans W; Ali-Hadji D; Schultz H; Claudepierre MC; Chartier C; Danel C; Bellocq JP
    Oncogene; 1992 May; 7(5):993-7. PubMed ID: 1373882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice.
    Gordon J; Del Valle L; Otte J; Khalili K
    Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
    Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
    Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smooth muscle and bone neoplasms in transgenic mice expressing SV40 T antigen.
    Wilkie TM; Schmidt RA; Baetscher M; Messing A
    Oncogene; 1994 Oct; 9(10):2889-95. PubMed ID: 8084593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medullary thyroid carcinomas in transgenic mice expressing a Polyoma carboxyl-terminal truncated middle-T and wild type small-T antigens.
    Felici A; Giorgio M; Krauzewicz N; Della Rocca C; Santoro M; Rovere P; Manni I; Amati P; Pozzi L
    Oncogene; 1999 Apr; 18(14):2387-95. PubMed ID: 10327060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.